Killela PJ, Reitman ZJ, Jiao Y, Bettegowda C, Agrawal N, Diaz LA Jr, Friedman AH, Friedman H, Gallia GL, Giovanella BC, Grollman AP, He TC, He Y, Hruban RH, Jallo GI, Mandahl N, Meeker AK, Mertens F, Netto GJ, Rasheed BA, Riggins GJ, Rosenquist TA, Schiffman M, Shih IeM, Theodorescu D, Torbenson MS, Velculescu VE, Wang TL, Wentzensen N, Wood LD, Zhang M, McLendon RE, Bigner DD, Kinzler KW, Vogelstein B, Papadopoulos N, Yan H

TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal.

Proc Natl Acad Sci U S A 110:6021-6 (2013)
DOI:10.1073/pnas.1303607110

Cevik D, Yildiz G, Ozturk M

Common telomerase reverse transcriptase promoter mutations in hepatocellular carcinomas from different geographical locations.

World J Gastroenterol 21:311-7 (2015)
DOI:10.3748/wjg.v21.i1.311

Pezzuto F, Buonaguro L, Buonaguro FM, Tornesello ML

Frequency and geographic distribution of TERT promoter mutations in primary hepatocellular carcinoma.

Infect Agent Cancer 12:27 (2017)
DOI:10.1186/s13027-017-0138-5

Huang DS, Wang Z, He XJ, Diplas BH, Yang R, Killela PJ, Meng Q, Ye ZY, Wang W, Jiang XT, Xu L, He XL, Zhao ZS, Xu WJ, Wang HJ, Ma YY, Xia YJ, Li L, Zhang RX, Jin T, Zhao ZK, Xu J, Yu S, Wu F, Liang J, Wang S, Jiao Y, Yan H, Tao HQ

Recurrent TERT promoter mutations identified in a large-scale study of multiple tumour types are associated with increased TERT expression and telomerase activation.

Eur J Cancer 51:969-76 (2015)
DOI:10.1016/j.ejca.2015.03.010